Literature DB >> 32868477

Author response: Miller Fisher syndrome and polyneuritis cranialis in COVID-19.

Julián Benito-León1, Antonio Méndez-Guerrero1, Consuelo Gutiérrez-Ortiz1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32868477     DOI： 10.1212/WNL.0000000000010405

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

Review 1.  Diagnostic and therapeutic agents that target alpha-synuclein in Parkinson's disease.

Authors:  Chukwunonso K Nwabufo; Omozojie P Aigbogun
Journal:  J Neurol       Date:  2022-07-13       Impact factor: 6.682

Review 2.  Nervous System Involvement in COVID-19: a Review of the Current Knowledge.

Authors:  Mahnaz Norouzi; Paniz Miar; Shaghayegh Norouzi; Parvaneh Nikpour
Journal:  Mol Neurobiol       Date:  2021-03-25       Impact factor: 5.590

Review 3.  SARS-CoV-2 Infection: Symptoms of the Nervous System and Implications for Therapy in Neurological Disorders.

Authors:  Jacek Losy
Journal:  Neurol Ther       Date:  2020-11-23

4.  Bickerstaff encephalitis after COVID-19.

Authors:  Lucía Llorente Ayuso; Pedro Torres Rubio; Rafael Fernando Beijinho do Rosário; María Luisa Giganto Arroyo; Fernando Sierra-Hidalgo
Journal:  J Neurol       Date:  2020-09-03       Impact factor: 4.849

5.  Guillain-Barré syndrome spectrum associated with COVID-19: an up-to-date systematic review of 73 cases.

Authors:  Samir Abu-Rumeileh; Ahmed Abdelhak; Matteo Foschi; Hayrettin Tumani; Markus Otto
Journal:  J Neurol       Date:  2020-08-25       Impact factor: 4.849

6.  Cytotoxic lesions of the corpus callosum (CLOCCs) associated with SARS-CoV-2 infection.

Authors:  Anthony Moreau; Amedee Ego; Frederic Vandergheynst; Fabio Silvio Taccone; Niloufar Sadeghi; Isabel Montesinos; Nicolas Gaspard; Julie Gorham
Journal:  J Neurol       Date:  2020-08-18       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.